A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical and Anti-Microbial Efficacy and Safety of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone in the Treatment of Subjects With Blepharoconjunctivitis.

Trial Profile

A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical and Anti-Microbial Efficacy and Safety of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone in the Treatment of Subjects With Blepharoconjunctivitis.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2014

At a glance

  • Drugs Azithromycin/dexamethasone (Primary) ; Azithromycin; Dexamethasone
  • Indications Infectious blepharoconjunctivitis
  • Focus Registrational; Therapeutic Use
  • Sponsors InSite Vision
  • Most Recent Events

    • 21 Mar 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 09 Jun 2009 Based on completion of the first phase III trial (700029501), a protocol amendment is under discussion with the US FDA.
    • 30 Oct 2008 Planned initiation date changed from 1 Oct 2008 to 1 Nov 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top